While now commonly applied for studying human brain function the value of functional magnetic resonance imaging in drug development has only recently been recognized. Here we describe the different functional magnetic resonance imaging techniques applied in Alzheimer's disease drug development with their applications, implementation guidelines, and potential pitfalls
Alzheimer's disease is a leading healthcare challenge facing our society today. Functional magnetic ...
Alzheimer's disease (AD), a progressive neurodegenerative disorder, is the most common cause of deme...
Functional neuroimaging has the potential to improve the decision-making process in the development ...
ABSTRACT The authors make a complete review of the potential clinical applications of traditional an...
Quantitative outcome variables in Alzheimer's disease (AD) are of interest because of their low long...
This review provides perspectives on the utility of magnetic resonance imaging (MRI) as a neuroimagi...
Alzheimer's disease (AD) is the most common form of dementia among neurodegenerative diseases. New a...
Of the many laboratory measures and techniques available for understanding and quantifying biologica...
Alzheimer disease (AD), the most common cause of dementia in the elderly, is a progressive neurodege...
Until now, our understanding of human brain pharmacology has depended on indirect assessments or ani...
Functional magnetic resonance imaging (FMRI) is a new technology for producing images of the brain t...
State-of-the-art radioactive drug development has become a helpful tool in new functional imaging te...
Critical to development of new therapies for Alzheimer's disease (AD) is the ability to detect clini...
Until now, our understanding of human brain pharmacology has depended on indirect assessments or ani...
Although many advances in understanding the cellular and molecular mechanisms for Alzheimer\u27s dis...
Alzheimer's disease is a leading healthcare challenge facing our society today. Functional magnetic ...
Alzheimer's disease (AD), a progressive neurodegenerative disorder, is the most common cause of deme...
Functional neuroimaging has the potential to improve the decision-making process in the development ...
ABSTRACT The authors make a complete review of the potential clinical applications of traditional an...
Quantitative outcome variables in Alzheimer's disease (AD) are of interest because of their low long...
This review provides perspectives on the utility of magnetic resonance imaging (MRI) as a neuroimagi...
Alzheimer's disease (AD) is the most common form of dementia among neurodegenerative diseases. New a...
Of the many laboratory measures and techniques available for understanding and quantifying biologica...
Alzheimer disease (AD), the most common cause of dementia in the elderly, is a progressive neurodege...
Until now, our understanding of human brain pharmacology has depended on indirect assessments or ani...
Functional magnetic resonance imaging (FMRI) is a new technology for producing images of the brain t...
State-of-the-art radioactive drug development has become a helpful tool in new functional imaging te...
Critical to development of new therapies for Alzheimer's disease (AD) is the ability to detect clini...
Until now, our understanding of human brain pharmacology has depended on indirect assessments or ani...
Although many advances in understanding the cellular and molecular mechanisms for Alzheimer\u27s dis...
Alzheimer's disease is a leading healthcare challenge facing our society today. Functional magnetic ...
Alzheimer's disease (AD), a progressive neurodegenerative disorder, is the most common cause of deme...
Functional neuroimaging has the potential to improve the decision-making process in the development ...